Thursday, October 16, 2014
FA & ACTIMMUNE Phase 2 Clinical Trial Results
FA & ACTIMMUNE Phase 2 Clinical Trial Results. Friedreich's Ataxia Analyst Day Presentation, Horizon Pharma plc, October 13, 2014
Friedreich Ataxia and close related scientific news. Topics related to rare diseases.